Table of Content

1 Study Coverage
1.1 Nervous System Medications Product Introduction
1.2 Market by Type
1.2.1 Global Nervous System Medications Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Anesthetic
1.2.3 Painkiller
1.2.4 Psychostimulants
1.2.5 Antiepileptic Drugs
1.2.6 Anti-Parkinson Drugs
1.2.7 Others
1.3 Market by Application
1.3.1 Global Nervous System Medications Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Nervous System Medications Sales Estimates and Forecasts 2018-2034
2.2 Global Nervous System Medications Revenue by Region
2.2.1 Global Nervous System Medications Revenue by Region: 2018 VS 2024 VS 2034
2.2.2 Global Nervous System Medications Revenue by Region (2018-2023)
2.2.3 Global Nervous System Medications Revenue by Region (2024-2034)
2.2.4 Global Nervous System Medications Revenue Market Share by Region (2018-2034)
2.3 Global Nervous System Medications Sales Estimates and Forecasts 2018-2034
2.4 Global Nervous System Medications Sales by Region
2.4.1 Global Nervous System Medications Sales by Region: 2018 VS 2024 VS 2034
2.4.2 Global Nervous System Medications Sales by Region (2018-2023)
2.4.3 Global Nervous System Medications Sales by Region (2024-2034)
2.4.4 Global Nervous System Medications Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Nervous System Medications Sales by Manufacturers
3.1.1 Global Nervous System Medications Sales by Manufacturers (2018-2023)
3.1.2 Global Nervous System Medications Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nervous System Medications in 2024
3.2 Global Nervous System Medications Revenue by Manufacturers
3.2.1 Global Nervous System Medications Revenue by Manufacturers (2018-2023)
3.2.2 Global Nervous System Medications Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Nervous System Medications Revenue in 2024
3.3 Global Key Players of Nervous System Medications, Industry Ranking, 2021 VS 2024 VS 2023
3.4 Global Nervous System Medications Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Nervous System Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Nervous System Medications, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Nervous System Medications, Product Offered and Application
3.8 Global Key Manufacturers of Nervous System Medications, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nervous System Medications Sales by Type
4.1.1 Global Nervous System Medications Historical Sales by Type (2018-2023)
4.1.2 Global Nervous System Medications Forecasted Sales by Type (2024-2034)
4.1.3 Global Nervous System Medications Sales Market Share by Type (2018-2034)
4.2 Global Nervous System Medications Revenue by Type
4.2.1 Global Nervous System Medications Historical Revenue by Type (2018-2023)
4.2.2 Global Nervous System Medications Forecasted Revenue by Type (2024-2034)
4.2.3 Global Nervous System Medications Revenue Market Share by Type (2018-2034)
4.3 Global Nervous System Medications Price by Type
4.3.1 Global Nervous System Medications Price by Type (2018-2023)
4.3.2 Global Nervous System Medications Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Nervous System Medications Sales by Application
5.1.1 Global Nervous System Medications Historical Sales by Application (2018-2023)
5.1.2 Global Nervous System Medications Forecasted Sales by Application (2024-2034)
5.1.3 Global Nervous System Medications Sales Market Share by Application (2018-2034)
5.2 Global Nervous System Medications Revenue by Application
5.2.1 Global Nervous System Medications Historical Revenue by Application (2018-2023)
5.2.2 Global Nervous System Medications Forecasted Revenue by Application (2024-2034)
5.2.3 Global Nervous System Medications Revenue Market Share by Application (2018-2034)
5.3 Global Nervous System Medications Price by Application
5.3.1 Global Nervous System Medications Price by Application (2018-2023)
5.3.2 Global Nervous System Medications Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Nervous System Medications Market Size by Type
6.1.1 US & Canada Nervous System Medications Sales by Type (2018-2034)
6.1.2 US & Canada Nervous System Medications Revenue by Type (2018-2034)
6.2 US & Canada Nervous System Medications Market Size by Application
6.2.1 US & Canada Nervous System Medications Sales by Application (2018-2034)
6.2.2 US & Canada Nervous System Medications Revenue by Application (2018-2034)
6.3 US & Canada Nervous System Medications Market Size by Country
6.3.1 US & Canada Nervous System Medications Revenue by Country: 2018 VS 2024 VS 2034
6.3.2 US & Canada Nervous System Medications Sales by Country (2018-2034)
6.3.3 US & Canada Nervous System Medications Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Nervous System Medications Market Size by Type
7.1.1 Europe Nervous System Medications Sales by Type (2018-2034)
7.1.2 Europe Nervous System Medications Revenue by Type (2018-2034)
7.2 Europe Nervous System Medications Market Size by Application
7.2.1 Europe Nervous System Medications Sales by Application (2018-2034)
7.2.2 Europe Nervous System Medications Revenue by Application (2018-2034)
7.3 Europe Nervous System Medications Market Size by Country
7.3.1 Europe Nervous System Medications Revenue by Country: 2018 VS 2024 VS 2034
7.3.2 Europe Nervous System Medications Sales by Country (2018-2034)
7.3.3 Europe Nervous System Medications Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Nervous System Medications Market Size
8.1.1 China Nervous System Medications Sales (2018-2034)
8.1.2 China Nervous System Medications Revenue (2018-2034)
8.2 China Nervous System Medications Market Size by Application
8.2.1 China Nervous System Medications Sales by Application (2018-2034)
8.2.2 China Nervous System Medications Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Nervous System Medications Market Size by Type
9.1.1 Asia Nervous System Medications Sales by Type (2018-2034)
9.1.2 Asia Nervous System Medications Revenue by Type (2018-2034)
9.2 Asia Nervous System Medications Market Size by Application
9.2.1 Asia Nervous System Medications Sales by Application (2018-2034)
9.2.2 Asia Nervous System Medications Revenue by Application (2018-2034)
9.3 Asia Nervous System Medications Sales by Region
9.3.1 Asia Nervous System Medications Revenue by Region: 2018 VS 2024 VS 2034
9.3.2 Asia Nervous System Medications Revenue by Region (2018-2034)
9.3.3 Asia Nervous System Medications Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Nervous System Medications Market Size by Type
10.1.1 Middle East, Africa and Latin America Nervous System Medications Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Nervous System Medications Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Nervous System Medications Market Size by Application
10.2.1 Middle East, Africa and Latin America Nervous System Medications Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Nervous System Medications Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Nervous System Medications Sales by Country
10.3.1 Middle East, Africa and Latin America Nervous System Medications Revenue by Country: 2018 VS 2024 VS 2034
10.3.2 Middle East, Africa and Latin America Nervous System Medications Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Nervous System Medications Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Pfizer Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Overview
11.2.3 Teva Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Teva Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Overview
11.3.3 Novartis Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Novartis Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 AstraZeneca Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Recent Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Overview
11.5.3 Takeda Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Takeda Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Takeda Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Johnson & Johnson Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 EliLilly
11.7.1 EliLilly Company Information
11.7.2 EliLilly Overview
11.7.3 EliLilly Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 EliLilly Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 EliLilly Recent Developments
11.8 Otsuka
11.8.1 Otsuka Company Information
11.8.2 Otsuka Overview
11.8.3 Otsuka Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Otsuka Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Otsuka Recent Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Overview
11.9.3 Merck Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Merck Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Recent Developments
11.10 Yangtze River Pharmaceutical
11.10.1 Yangtze River Pharmaceutical Company Information
11.10.2 Yangtze River Pharmaceutical Overview
11.10.3 Yangtze River Pharmaceutical Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Yangtze River Pharmaceutical Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yangtze River Pharmaceutical Recent Developments
11.11 Humanwell Healthcare
11.11.1 Humanwell Healthcare Company Information
11.11.2 Humanwell Healthcare Overview
11.11.3 Humanwell Healthcare Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Humanwell Healthcare Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Humanwell Healthcare Recent Developments
11.12 CSPC-NBP Pharmaceutical
11.12.1 CSPC-NBP Pharmaceutical Company Information
11.12.2 CSPC-NBP Pharmaceutical Overview
11.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 CSPC-NBP Pharmaceutical Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 CSPC-NBP Pharmaceutical Recent Developments
11.13 Nhwa Pharmaceutical
11.13.1 Nhwa Pharmaceutical Company Information
11.13.2 Nhwa Pharmaceutical Overview
11.13.3 Nhwa Pharmaceutical Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Nhwa Pharmaceutical Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Nhwa Pharmaceutical Recent Developments
11.14 Qilu Pharma
11.14.1 Qilu Pharma Company Information
11.14.2 Qilu Pharma Overview
11.14.3 Qilu Pharma Nervous System Medications Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Qilu Pharma Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Qilu Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nervous System Medications Industry Chain Analysis
12.2 Nervous System Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nervous System Medications Production Mode & Process
12.4 Nervous System Medications Sales and Marketing
12.4.1 Nervous System Medications Sales Channels
12.4.2 Nervous System Medications Distributors
12.5 Nervous System Medications Customers
13 Market Dynamics
13.1 Nervous System Medications Industry Trends
13.2 Nervous System Medications Market Drivers
13.3 Nervous System Medications Market Challenges
13.4 Nervous System Medications Market Restraints
14 Key Findings in The Global Nervous System Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Nervous System Medications Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Anesthetic
Table 3. Major Manufacturers of Painkiller
Table 4. Major Manufacturers of Psychostimulants
Table 5. Major Manufacturers of Antiepileptic Drugs
Table 6. Major Manufacturers of Anti-Parkinson Drugs
Table 7. Major Manufacturers of Others
Table 8. Global Nervous System Medications Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Nervous System Medications Revenue Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Nervous System Medications Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Nervous System Medications Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Nervous System Medications Revenue Market Share by Region (2018-2023)
Table 13. Global Nervous System Medications Revenue Market Share by Region (2024-2034)
Table 14. Global Nervous System Medications Sales Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 15. Global Nervous System Medications Sales by Region (2018-2023) & (K Units)
Table 16. Global Nervous System Medications Sales by Region (2024-2034) & (K Units)
Table 17. Global Nervous System Medications Sales Market Share by Region (2018-2023)
Table 18. Global Nervous System Medications Sales Market Share by Region (2024-2034)
Table 19. Global Nervous System Medications Sales by Manufacturers (2018-2023) & (K Units)
Table 20. Global Nervous System Medications Sales Share by Manufacturers (2018-2023)
Table 21. Global Nervous System Medications Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Nervous System Medications Revenue Share by Manufacturers (2018-2023)
Table 23. Global Key Players of Nervous System Medications, Industry Ranking, 2021 VS 2024 VS 2023
Table 24. Nervous System Medications Price by Manufacturers 2018-2023 (US$/Unit)
Table 25. Global Nervous System Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Nervous System Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nervous System Medications as of 2024)
Table 27. Global Key Manufacturers of Nervous System Medications, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Nervous System Medications, Product Offered and Application
Table 29. Global Key Manufacturers of Nervous System Medications, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Nervous System Medications Sales by Type (2018-2023) & (K Units)
Table 32. Global Nervous System Medications Sales by Type (2024-2034) & (K Units)
Table 33. Global Nervous System Medications Sales Share by Type (2018-2023)
Table 34. Global Nervous System Medications Sales Share by Type (2024-2034)
Table 35. Global Nervous System Medications Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Nervous System Medications Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Nervous System Medications Revenue Share by Type (2018-2023)
Table 38. Global Nervous System Medications Revenue Share by Type (2024-2034)
Table 39. Nervous System Medications Price by Type (2018-2023) & (US$/Unit)
Table 40. Global Nervous System Medications Price Forecast by Type (2024-2034) & (US$/Unit)
Table 41. Global Nervous System Medications Sales by Application (2018-2023) & (K Units)
Table 42. Global Nervous System Medications Sales by Application (2024-2034) & (K Units)
Table 43. Global Nervous System Medications Sales Share by Application (2018-2023)
Table 44. Global Nervous System Medications Sales Share by Application (2024-2034)
Table 45. Global Nervous System Medications Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Nervous System Medications Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Nervous System Medications Revenue Share by Application (2018-2023)
Table 48. Global Nervous System Medications Revenue Share by Application (2024-2034)
Table 49. Nervous System Medications Price by Application (2018-2023) & (US$/Unit)
Table 50. Global Nervous System Medications Price Forecast by Application (2024-2034) & (US$/Unit)
Table 51. US & Canada Nervous System Medications Sales by Type (2018-2023) & (K Units)
Table 52. US & Canada Nervous System Medications Sales by Type (2024-2034) & (K Units)
Table 53. US & Canada Nervous System Medications Revenue by Type (2018-2023) & (US$ Million)
Table 54. US & Canada Nervous System Medications Revenue by Type (2024-2034) & (US$ Million)
Table 55. US & Canada Nervous System Medications Sales by Application (2018-2023) & (K Units)
Table 56. US & Canada Nervous System Medications Sales by Application (2024-2034) & (K Units)
Table 57. US & Canada Nervous System Medications Revenue by Application (2018-2023) & (US$ Million)
Table 58. US & Canada Nervous System Medications Revenue by Application (2024-2034) & (US$ Million)
Table 59. US & Canada Nervous System Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. US & Canada Nervous System Medications Revenue by Country (2018-2023) & (US$ Million)
Table 61. US & Canada Nervous System Medications Revenue by Country (2024-2034) & (US$ Million)
Table 62. US & Canada Nervous System Medications Sales by Country (2018-2023) & (K Units)
Table 63. US & Canada Nervous System Medications Sales by Country (2024-2034) & (K Units)
Table 64. Europe Nervous System Medications Sales by Type (2018-2023) & (K Units)
Table 65. Europe Nervous System Medications Sales by Type (2024-2034) & (K Units)
Table 66. Europe Nervous System Medications Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Nervous System Medications Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Nervous System Medications Sales by Application (2018-2023) & (K Units)
Table 69. Europe Nervous System Medications Sales by Application (2024-2034) & (K Units)
Table 70. Europe Nervous System Medications Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Nervous System Medications Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Nervous System Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Nervous System Medications Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Nervous System Medications Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Nervous System Medications Sales by Country (2018-2023) & (K Units)
Table 76. Europe Nervous System Medications Sales by Country (2024-2034) & (K Units)
Table 77. China Nervous System Medications Sales by Type (2018-2023) & (K Units)
Table 78. China Nervous System Medications Sales by Type (2024-2034) & (K Units)
Table 79. China Nervous System Medications Revenue by Type (2018-2023) & (US$ Million)
Table 80. China Nervous System Medications Revenue by Type (2024-2034) & (US$ Million)
Table 81. China Nervous System Medications Sales by Application (2018-2023) & (K Units)
Table 82. China Nervous System Medications Sales by Application (2024-2034) & (K Units)
Table 83. China Nervous System Medications Revenue by Application (2018-2023) & (US$ Million)
Table 84. China Nervous System Medications Revenue by Application (2024-2034) & (US$ Million)
Table 85. Asia Nervous System Medications Sales by Type (2018-2023) & (K Units)
Table 86. Asia Nervous System Medications Sales by Type (2024-2034) & (K Units)
Table 87. Asia Nervous System Medications Revenue by Type (2018-2023) & (US$ Million)
Table 88. Asia Nervous System Medications Revenue by Type (2024-2034) & (US$ Million)
Table 89. Asia Nervous System Medications Sales by Application (2018-2023) & (K Units)
Table 90. Asia Nervous System Medications Sales by Application (2024-2034) & (K Units)
Table 91. Asia Nervous System Medications Revenue by Application (2018-2023) & (US$ Million)
Table 92. Asia Nervous System Medications Revenue by Application (2024-2034) & (US$ Million)
Table 93. Asia Nervous System Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 94. Asia Nervous System Medications Revenue by Region (2018-2023) & (US$ Million)
Table 95. Asia Nervous System Medications Revenue by Region (2024-2034) & (US$ Million)
Table 96. Asia Nervous System Medications Sales by Region (2018-2023) & (K Units)
Table 97. Asia Nervous System Medications Sales by Region (2024-2034) & (K Units)
Table 98. Middle East, Africa and Latin America Nervous System Medications Sales by Type (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Nervous System Medications Sales by Type (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Nervous System Medications Revenue by Type (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Nervous System Medications Revenue by Type (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Nervous System Medications Sales by Application (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Nervous System Medications Sales by Application (2024-2034) & (K Units)
Table 104. Middle East, Africa and Latin America Nervous System Medications Revenue by Application (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Nervous System Medications Revenue by Application (2024-2034) & (US$ Million)
Table 106. Middle East, Africa and Latin America Nervous System Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 107. Middle East, Africa and Latin America Nervous System Medications Revenue by Country (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Nervous System Medications Revenue by Country (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Nervous System Medications Sales by Country (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Nervous System Medications Sales by Country (2024-2034) & (K Units)
Table 111. Pfizer Company Information
Table 112. Pfizer Description and Major Businesses
Table 113. Pfizer Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Pfizer Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Pfizer Recent Developments
Table 116. Teva Company Information
Table 117. Teva Description and Major Businesses
Table 118. Teva Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Teva Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Teva Recent Developments
Table 121. Novartis Company Information
Table 122. Novartis Description and Major Businesses
Table 123. Novartis Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Novartis Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Novartis Recent Developments
Table 126. AstraZeneca Company Information
Table 127. AstraZeneca Description and Major Businesses
Table 128. AstraZeneca Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. AstraZeneca Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. AstraZeneca Recent Developments
Table 131. Takeda Company Information
Table 132. Takeda Description and Major Businesses
Table 133. Takeda Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Takeda Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Takeda Recent Developments
Table 136. Johnson & Johnson Company Information
Table 137. Johnson & Johnson Description and Major Businesses
Table 138. Johnson & Johnson Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Johnson & Johnson Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Johnson & Johnson Recent Developments
Table 141. EliLilly Company Information
Table 142. EliLilly Description and Major Businesses
Table 143. EliLilly Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. EliLilly Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. EliLilly Recent Developments
Table 146. Otsuka Company Information
Table 147. Otsuka Description and Major Businesses
Table 148. Otsuka Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Otsuka Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Otsuka Recent Developments
Table 151. Merck Company Information
Table 152. Merck Description and Major Businesses
Table 153. Merck Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. Merck Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Merck Recent Developments
Table 156. Yangtze River Pharmaceutical Company Information
Table 157. Yangtze River Pharmaceutical Description and Major Businesses
Table 158. Yangtze River Pharmaceutical Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. Yangtze River Pharmaceutical Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Yangtze River Pharmaceutical Recent Developments
Table 161. Humanwell Healthcare Company Information
Table 162. Humanwell Healthcare Description and Major Businesses
Table 163. Humanwell Healthcare Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Humanwell Healthcare Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Humanwell Healthcare Recent Developments
Table 166. CSPC-NBP Pharmaceutical Company Information
Table 167. CSPC-NBP Pharmaceutical Description and Major Businesses
Table 168. CSPC-NBP Pharmaceutical Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 169. CSPC-NBP Pharmaceutical Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. CSPC-NBP Pharmaceutical Recent Developments
Table 171. Nhwa Pharmaceutical Company Information
Table 172. Nhwa Pharmaceutical Description and Major Businesses
Table 173. Nhwa Pharmaceutical Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 174. Nhwa Pharmaceutical Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Nhwa Pharmaceutical Recent Developments
Table 176. Qilu Pharma Company Information
Table 177. Qilu Pharma Description and Major Businesses
Table 178. Qilu Pharma Nervous System Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 179. Qilu Pharma Nervous System Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Qilu Pharma Recent Developments
Table 181. Key Raw Materials Lists
Table 182. Raw Materials Key Suppliers Lists
Table 183. Nervous System Medications Distributors List
Table 184. Nervous System Medications Customers List
Table 185. Nervous System Medications Market Trends
Table 186. Nervous System Medications Market Drivers
Table 187. Nervous System Medications Market Challenges
Table 188. Nervous System Medications Market Restraints
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Nervous System Medications Product Picture
Figure 2. Global Nervous System Medications Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Nervous System Medications Market Share by Type in 2024 & 2034
Figure 4. Anesthetic Product Picture
Figure 5. Painkiller Product Picture
Figure 6. Psychostimulants Product Picture
Figure 7. Antiepileptic Drugs Product Picture
Figure 8. Anti-Parkinson Drugs Product Picture
Figure 9. Others Product Picture
Figure 10. Global Nervous System Medications Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 11. Global Nervous System Medications Market Share by Application in 2024 & 2034
Figure 12. Hospital Pharmacy
Figure 13. Retail Pharmacy
Figure 14. Online Pharmacy
Figure 15. Nervous System Medications Report Years Considered
Figure 16. Global Nervous System Medications Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Nervous System Medications Revenue 2018-2034 (US$ Million)
Figure 18. Global Nervous System Medications Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global Nervous System Medications Revenue Market Share by Region (2018-2034)
Figure 20. Global Nervous System Medications Sales 2018-2034 ((K Units)
Figure 21. Global Nervous System Medications Sales Market Share by Region (2018-2034)
Figure 22. US & Canada Nervous System Medications Sales YoY (2018-2034) & (K Units)
Figure 23. US & Canada Nervous System Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Nervous System Medications Sales YoY (2018-2034) & (K Units)
Figure 25. Europe Nervous System Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Nervous System Medications Sales YoY (2018-2034) & (K Units)
Figure 27. China Nervous System Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Asia (excluding China) Nervous System Medications Sales YoY (2018-2034) & (K Units)
Figure 29. Asia (excluding China) Nervous System Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Nervous System Medications Sales YoY (2018-2034) & (K Units)
Figure 31. Middle East, Africa and Latin America Nervous System Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Nervous System Medications Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 33. The Top 5 and 10 Largest Manufacturers of Nervous System Medications in the World: Market Share by Nervous System Medications Revenue in 2024
Figure 34. Global Nervous System Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global Nervous System Medications Sales Market Share by Type (2018-2034)
Figure 36. Global Nervous System Medications Revenue Market Share by Type (2018-2034)
Figure 37. Global Nervous System Medications Sales Market Share by Application (2018-2034)
Figure 38. Global Nervous System Medications Revenue Market Share by Application (2018-2034)
Figure 39. US & Canada Nervous System Medications Sales Market Share by Type (2018-2034)
Figure 40. US & Canada Nervous System Medications Revenue Market Share by Type (2018-2034)
Figure 41. US & Canada Nervous System Medications Sales Market Share by Application (2018-2034)
Figure 42. US & Canada Nervous System Medications Revenue Market Share by Application (2018-2034)
Figure 43. US & Canada Nervous System Medications Revenue Share by Country (2018-2034)
Figure 44. US & Canada Nervous System Medications Sales Share by Country (2018-2034)
Figure 45. U.S. Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Nervous System Medications Sales Market Share by Type (2018-2034)
Figure 48. Europe Nervous System Medications Revenue Market Share by Type (2018-2034)
Figure 49. Europe Nervous System Medications Sales Market Share by Application (2018-2034)
Figure 50. Europe Nervous System Medications Revenue Market Share by Application (2018-2034)
Figure 51. Europe Nervous System Medications Revenue Share by Country (2018-2034)
Figure 52. Europe Nervous System Medications Sales Share by Country (2018-2034)
Figure 53. Germany Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 54. France Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 58. China Nervous System Medications Sales Market Share by Type (2018-2034)
Figure 59. China Nervous System Medications Revenue Market Share by Type (2018-2034)
Figure 60. China Nervous System Medications Sales Market Share by Application (2018-2034)
Figure 61. China Nervous System Medications Revenue Market Share by Application (2018-2034)
Figure 62. Asia Nervous System Medications Sales Market Share by Type (2018-2034)
Figure 63. Asia Nervous System Medications Revenue Market Share by Type (2018-2034)
Figure 64. Asia Nervous System Medications Sales Market Share by Application (2018-2034)
Figure 65. Asia Nervous System Medications Revenue Market Share by Application (2018-2034)
Figure 66. Asia Nervous System Medications Revenue Share by Region (2018-2034)
Figure 67. Asia Nervous System Medications Sales Share by Region (2018-2034)
Figure 68. Japan Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 69. South Korea Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 70. China Taiwan Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 71. Southeast Asia Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 72. India Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Nervous System Medications Sales Market Share by Type (2018-2034)
Figure 74. Middle East, Africa and Latin America Nervous System Medications Revenue Market Share by Type (2018-2034)
Figure 75. Middle East, Africa and Latin America Nervous System Medications Sales Market Share by Application (2018-2034)
Figure 76. Middle East, Africa and Latin America Nervous System Medications Revenue Market Share by Application (2018-2034)
Figure 77. Middle East, Africa and Latin America Nervous System Medications Revenue Share by Country (2018-2034)
Figure 78. Middle East, Africa and Latin America Nervous System Medications Sales Share by Country (2018-2034)
Figure 79. Brazil Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 80. Mexico Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 81. Turkey Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 82. Israel Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 83. GCC Countries Nervous System Medications Revenue (2018-2034) & (US$ Million)
Figure 84. Nervous System Medications Value Chain
Figure 85. Nervous System Medications Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed